GSK Plc risk profile
32 Normal where most of the sector sits
Measured 1 September 2026 from GSK's filed statements. Recomputed nightly.
32 (Normal), driven by Competitive position at 42, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 29 | Normal | Stable | One-year price volatility — 27.2% |
| Operating pressure | 21 | Normal | Easing | Operating-margin drift — +2.6 percentage points |
| Cash conversion | 28 | Normal | Worsening | Capital spending against operating cash — 0.39x |
| Leverage and coverage | 29 | Normal | Easing | Current ratio — 0.82x |
| Competitive position | 42 | Elevated | Stable | Revenue-growth gap against peers — -18.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.